BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Sep 19, 2025; 15(9): 108497
Published online Sep 19, 2025. doi: 10.5498/wjp.v15.i9.108497
Advances in transcranial magnetic stimulation for psychological symptom management in Parkinson’s disease
Xiao-Li Zhou, Yan Li, Wan Xia, Ying-Ying Zheng, Ai-Ping Wu
Xiao-Li Zhou, Wan Xia, Ying-Ying Zheng, Ai-Ping Wu, Department of Rehabilitation, Zhejiang Hospital, Hangzhou 310012, Zhejiang Province, China
Yan Li, Department of Neurology, Zhejiang Hospital, Hangzhou 310012, Zhejiang Province, China
Author contributions: Zhou XL conducted literature review and initial drafting; Li Y provided neurological expertise and clinical experience; Xia W handled literature screening and data organization; Zheng YY focused on transcranial magnetic stimulation applications and manuscript revision, and corresponding author Wu AP oversaw research design, overall coordination, and final review.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Ai-Ping Wu, MD, Doctor, Department of Rehabilitation, Zhejiang Hospital, No. 12 Lingyin Road, Xihu District, Hangzhou 310012, Zhejiang Province, China. waiping_apwu@163.com
Received: May 16, 2025
Revised: June 16, 2025
Accepted: July 18, 2025
Published online: September 19, 2025
Processing time: 102 Days and 1.4 Hours
Core Tip

Core Tip: This review summarizes recent advances in transcranial magnetic stimulation (TMS) for managing psychological symptoms in Parkinson’s disease, including depression, anxiety, cognitive impairment, impulse control disorders, and sleep disturbances. It highlights the neurophysiological mechanisms of TMS, such as modulation of the prefrontal-striatal dopamine pathway and promotion of neuroplasticity. Clinical applications of repetitive TMS and theta burst stimulation are discussed, along with individualized parameter optimization strategies. The article also outlines future directions involving deep TMS, neuronavigation, and personalized protocols, offering novel insights into non-invasive neuromodulation for comprehensive symptom management in Parkinson’s disease.